BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35834142)

  • 1. Factors Influencing Non-sentinel Lymph Node Involvement in Patients with Positive Sentinel Lymph Node(s) After Neoadjuvant Chemotherapy for Breast Cancer.
    Sanders SB; Hoskin TL; Stafford AP; Boughey JC
    Ann Surg Oncol; 2022 Nov; 29(12):7769-7778. PubMed ID: 35834142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nomogram to predict non-sentinel lymph node metastasis in patients with initial cN+ breast cancer that downstages to cN0 after neoadjuvant chemotherapy.
    Cheng M; Zhuang X; Zhang L; Zhu T; Lin Y; Yang M; Ji F; Yang C; Gao H; Wang K
    J Surg Oncol; 2020 Sep; 122(3):373-381. PubMed ID: 32436217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors of non-sentinel lymph node metastasis in breast cancer with 1-2 sentinel lymph node macrometastases underwent total mastectomy: a case-control study.
    Huang Z; Wu Z; Zou QQ; Xie YJ; Li LH; Huang YP; Wu FM; Huang D; Pan YH; Yang JR
    World J Surg Oncol; 2023 Apr; 21(1):125. PubMed ID: 37024930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of non-sentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node.
    Reynders A; Brouckaert O; Smeets A; Laenen A; Yoshihara E; Persyn F; Floris G; Leunen K; Amant F; Soens J; Van Ongeval C; Moerman P; Vergote I; Christiaens MR; Staelens G; Van Eygen K; Vanneste A; Van Dam P; Colpaert C; Neven P
    Breast; 2014 Aug; 23(4):453-9. PubMed ID: 24768478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locoregional Management of the Axilla in Mastectomy Patients with One or Two Positive Sentinel Nodes: The Role of Intraoperative Pathology.
    Davis J; Boughey JC; Hoskin TL; Day CN; Cheville JC; Piltin MA; Hieken TJ
    Clin Breast Cancer; 2021 Oct; 21(5):458-465. PubMed ID: 33839043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of non-sentinel lymph node metastasis in breast cancer patients.
    Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE;
    Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors of non-sentinel lymph node metastasis in 443 breast cancer patients with sentinel lymph node-positive.
    Cai SL; Wei RM; Han L; Chen XG; Gong GX; Lin XQ; Zhang J; Chen HD
    Medicine (Baltimore); 2022 Jul; 101(29):e29286. PubMed ID: 35866760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To Dissect or Not to Dissect: Can We Predict the Presence of Four or More Axillary Lymph Node Metastases in Postmenopausal Women with Clinically Node-Negative Breast Cancer?
    Farley C; Bassett R; Meric-Bernstam F; Bedrosian I; Caudle A; DeSnyder S; Hunt K; Kuerer H; Singh P; Sun S; Tamirisa N; Teshome M; Hwang RF
    Ann Surg Oncol; 2023 Dec; 30(13):8327-8334. PubMed ID: 37670121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Non-sentinel Lymph Node Metastases in Patients with a Positive Sentinel Lymph Node After Neoadjuvant Chemotherapy.
    Barron AU; Hoskin TL; Boughey JC
    Ann Surg Oncol; 2018 Oct; 25(10):2867-2874. PubMed ID: 29956095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive non-sentinel axillary lymph nodes in breast cancer with 1-2 sentinel lymph node metastases.
    Zheng J; Cai S; Song H; Wang Y; Han X; Wu H; Gao Z; Qiu F
    Medicine (Baltimore); 2018 Nov; 97(44):e13015. PubMed ID: 30383658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection?
    Moo TA; Edelweiss M; Hajiyeva S; Stempel M; Raiss M; Zabor EC; Barrio A; Morrow M
    Ann Surg Oncol; 2018 Jun; 25(6):1488-1494. PubMed ID: 29572705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy and timing of sentinel lymph node biopsy in different molecular subtypes of breast cancer with clinically negative axilla.
    Bi Z; Liu J; Chen P; Liu Y; Zhao T; Wang C; Zhang Z; Sun X; Qiu P; Cong B; Song X; Wang Y
    Breast Cancer; 2019 May; 26(3):373-377. PubMed ID: 30666563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-sentinel axillary tumor burden applying the ACOSOG Z0011 eligibility criteria to a large routine cohort.
    Riedel F; Heil J; Feißt M; Rezai M; Moderow M; Sohn C; Schütz F; Golatta M; Hennigs A
    Breast Cancer Res Treat; 2019 Sep; 177(2):457-467. PubMed ID: 31236814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Lymph Node Status Prior to Neoadjuvant Chemotherapy Influence the Number of Sentinel Nodes Removed?
    Baker JL; Muhsen S; Zabor EC; Stempel M; Gemignani ML
    Ann Surg Oncol; 2019 Feb; 26(2):336-342. PubMed ID: 30506175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary Axillary Management in cT1-2N0 Breast Cancer with One or Two Positive Sentinel Lymph Nodes: Factors Associated with Completion Axillary Lymph Node Dissection Within the National Cancer Database.
    Stafford AP; Hoskin TL; Day CN; Sanders SB; Boughey JC
    Ann Surg Oncol; 2022 Aug; 29(8):4740-4749. PubMed ID: 35451727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of nonsentinel lymph node metastasis in patients with breast cancer with metastasis in the sentinel node.
    Zhou Y; Huang X; Mao F; Lin Y; Shen S; Guan J; Zhang X; Sun Q
    Medicine (Baltimore); 2019 Jan; 98(1):e13916. PubMed ID: 30608418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial.
    Boughey JC; Yu H; Dugan CL; Piltin MA; Postlewait L; Son JD; Edmiston KK; Godellas CV; Lee MC; Carr MJ; Tonneson JE; Crown A; Lancaster RB; Woriax HE; Ewing CA; Chau HS; Patterson AK; Wong JM; Alvarado MD; Yang RL; Chan TW; Sheade JB; Ahrendt GM; Larson KE; Switalla K; Tuttle TM; Tchou JC; Rao R; Tamirisa N; Singh P; Gould RE; Terando A; Sauder C; Hewitt K; Chiba A; Esserman LJ; Mukhtar RA
    Ann Surg Oncol; 2023 Oct; 30(11):6401-6410. PubMed ID: 37380911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Factors for Nonsentinel Lymph Node Metastasis in Patients With Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy: Nomogram for Predicting Nonsentinel Lymph Node Metastasis.
    Ryu JM; Lee SK; Kim JY; Yu J; Kim SW; Lee JE; Han SH; Jung YS; Nam SJ
    Clin Breast Cancer; 2017 Nov; 17(7):550-558. PubMed ID: 28454926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subsequent axillary surgery after sentinel lymph node biopsy: results from the BreastSurgANZ Quality Audit 2006-2010.
    Chong C; Walters D; de Silva P; Taylor C; Spillane A; Kollias J; Pyke C; Campbell I; Maddern G
    Breast; 2013 Dec; 22(6):1215-9. PubMed ID: 24157405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clipping a Positive Lymph Node Improves Accuracy of Nodal Staging After Neoadjuvant Chemotherapy for Breast Cancer Patients, but Does It Drive Management Changes?
    Costarelli L; Arienzo F; Broglia L; La Pinta M; Scavina P; Meli EZ; Colavito MH; Ascarelli A; Campagna D; Mastropietro T; Manna E; Amato M; Andrulli AD; Schiavone A; Minelli M; Fortunato L
    Ann Surg Oncol; 2024 May; 31(5):3186-3193. PubMed ID: 38427160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.